Navigation Links
Final agenda available for CRF Conference on Stem Cell Therapy for Heart Disease
Date:1/8/2014

WHAT:

The final agenda for the Conference on Cell Therapy for Cardiovascular Disease, sponsored by the Cardiovascular Research Foundation, is now available online at http://www.crf.org/celltherapy/the-conference/agenda. The conference, which will be held January 22-24, 2014, is the premier meeting dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.

This year's conference will focus on preclinical and clinical studies and their paths toward optimizing outcomes. The most promising molecular, cellular, and tissue products will be presented. Presentations of key activities at state, federal, and international levels will also be highlighted as measures of the progress ahead.

WHY:

Recent advances in stem cell research demonstrate great potential as breakthrough therapies for conditions like diabetes, Parkinson's and heart disease. Now in its 13th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has provided both a strong foundation for the conduct of large scale, pivotal studies, as well as insights into mechanisms of cardiovascular repair that will enhance the design of further investigation.

Renowned thought leaders in this field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies. Sessions will focus on:

  • Molecular and Cellular Pathways: Regulating Biologic Function
  • Mechanistic Insights and Hypothesis
  • Moving Toward Tissue as Therapy: Micro- and Macro-Structure Strategies
  • STEMI and Acute Injury Studies
  • Chronic Injury and Vascular Insufficiency
  • Chronic Left Ventricular Dysfunction and Heart Failure
  • Patients-In-Need: Defining and Refining our Approach to Target Populations
  • Data in Hand: Looking for Answers in Meta-Analytic Studies
  • Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine

WHO:

Course Director

Warren Sherman, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Course Co-Directors

Jozef Bartunek, MD, PhD

Henricus J. Duckers, MD, PhD

Amit Patel, MD, MS

Marc S. Penn, MD, PhD

Thomas Povsic, MD

Gordana Vunjak-Novakovic, PhD

Joseph Wu, MD, PhD

Wojtek Wojakowski, MD, PhD

WHEN:

January 22-24, 2014

WHERE:

Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

For more information visit: http://www.crf.org/celltherapy.

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related biology news :

1. Planet under Pressure conference, London: Final statement
2. Sequencing works in clinical setting to help -- finally -- get a diagnosis
3. NYBG press publishes final volume of landmark Intermountain Flora series
4. Finalists of air pollution sensor challenge announced
5. Dark matter made visible before the final cut
6. Researchers attack HIVs final defenses before drug-resistant mutations emerge
7. WPI Biomedical Technology in final 4 of international business plan contest
8. Final chapter to 60-year-old blood group mystery
9. Fueling fitness on the final frontier
10. Finally mapped: The brain region that distinguishes bits from bounty
11. The Sackler Institute unveils a global research agenda for nutrition science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... enabling healthier lives through the development of innovative products ... the United States denied its ... the claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 ... criteria established by the Supreme Court,s Mayo Collaborative Services ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the ... today the Clinical Reach Virtual Patient Encounter CONSULT module which enables both ... physician and clinical trial team. , Using the CONSULT module, patients and physicians can ...
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
Breaking Biology Technology: